Mohammed Al Abadie*, Hussain Tukmatchy, Daniel Adam and Lamis Sharaf El Din
National Health Service (NHS) Community Dermatology Clinics (Health Harmonie), United Kingdom
*Corresponding Author: Mohamed Al Abadie, National Health Service (NHS) Community Dermatology Clinics (Health Harmonie), United Kingdom.
Received: August 24, 2021; Published: September 29, 2021
Melasma is a disfiguring skin disease that is often challenging to treat. Treatments options including topical remedies, laser therapies and systemic medications vary widely in efficacy and tend to display safety concerns. Systemic tranexamic acid has been widely feared in practice as a treatment option, despite growing evidence in literature of its high efficacy and safety in the management of melasma. In this article, we discuss the efficacy and safety of oral tranexamic acid in the treatment of melasma.
Keywords: Melasma; Chloasma; Tranexamic Acid; Hydroquinone; Tretinoin
Citation: Mohammed Al Abadie., et al. “The Efficacy and Safety of Oral Tranexamic Acid (TXA) in the Treatment of Melasma”. Acta Scientific Women's Health 3.10 (2021):.
Copyright: © 2021 Mohammed Al Abadie., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.